• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?

作者信息

Beevers D G, Sleight P

机构信息

City Hospital, Birmingham.

出版信息

BMJ. 1996 May 4;312(7039):1143-5. doi: 10.1136/bmj.312.7039.1143.

DOI:10.1136/bmj.312.7039.1143
PMID:8620133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2350648/
Abstract
摘要

相似文献

1
Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?用于治疗高血压的短效二氢吡啶类（血管舒张型）钙通道阻滞剂：存在风险吗？
BMJ. 1996 May 4;312(7039):1143-5. doi: 10.1136/bmj.312.7039.1143.
2
[Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].二氢吡啶类与非二氢吡啶类钙拮抗剂联合应用治疗动脉高血压患者的降压疗效及耐受性
Kardiologiia. 2007;47(11):44-5.
3
Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.瓦尼地平。AE 0047，卡尔布伦，GJ 0956，瓦尼地平。
Drugs R D. 2002;3(5):331-6. doi: 10.2165/00126839-200203050-00007.
4
Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.长效与短效钙通道阻滞剂对老年急性心肌梗死幸存者的影响。
J Am Geriatr Soc. 1999 May;47(5):512-7. doi: 10.1111/j.1532-5415.1999.tb02562.x.
5
Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.1,4-二氢吡啶类钙通道阻滞剂的差异效应：治疗意义
J Clin Pharmacol. 1987 Nov;27(11):825-34. doi: 10.1002/j.1552-4604.1987.tb05576.x.
6
Dihydropyridine calcium channel antagonists in the management of hypertension.二氢吡啶类钙通道拮抗剂在高血压治疗中的应用
Drugs. 2007;67(9):1309-27. doi: 10.2165/00003495-200767090-00005.
7
Use of calcium channel blockers in hypertension.钙通道阻滞剂在高血压治疗中的应用。
Adv Intern Med. 1998;43:533-62.
8
[Evolution of the market of calcium dihydropyridinic antagonists and their use in the treatment of chronic forms of ischemic heart disease].[二氢吡啶类钙拮抗剂市场的演变及其在慢性缺血性心脏病治疗中的应用]
Lik Sprava. 2002 Jul-Sep(5-6):16-20.
9
Calcium channel blocker debate: true lies?钙通道阻滞剂之争：是真相还是谎言？
Cardiovasc Drugs Ther. 1996 Sep;10(4):413-5. doi: 10.1007/BF00051105.
10
Case studies in hypertension. Dihydropyridine/nondihydropyridine calcium channel blocker combination therapy.高血压病例研究。二氢吡啶类/非二氢吡啶类钙通道阻滞剂联合治疗
J Clin Hypertens (Greenwich). 2005 Jan;7(1):50-3. doi: 10.1111/j.1524-6175.2005.04091.x.

引用本文的文献

1
Amlodipine and valsartan as components of a rational and effective fixed-dose combination.氨氯地平和缬沙坦作为合理有效的固定剂量复方制剂的组成成分。
Vasc Health Risk Manag. 2009;5(1):165-74. doi: 10.2147/vhrm.s3134. Epub 2009 Apr 8.
2
The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension.血管紧张素转换酶抑制剂在高血压治疗中的作用。
Curr Cardiol Rep. 2001 Nov;3(6):511-8. doi: 10.1007/s11886-001-0074-1.
3
Evidence for the risk of calcium channel blockers in hypertension was selective.钙通道阻滞剂治疗高血压存在风险的证据具有选择性。
BMJ. 1996 Nov 16;313(7067):1259-60. doi: 10.1136/bmj.313.7067.1259c.

本文引用的文献

1
Calcium antagonists during and after myocardial infarction.心肌梗死期间及之后使用的钙拮抗剂。
Drugs. 1996 Feb;51(2):216-25. doi: 10.2165/00003495-199651020-00003.
2
Verapamil following uncomplicated myocardial infarction: promising, but not proven.
Am J Cardiol. 1996 Feb 15;77(5):421-2. doi: 10.1016/s0002-9149(97)89376-9.
3
Established populations for epidemiologic studies of the elderly: study design and methodology.老年人流行病学研究的既定人群：研究设计与方法
Aging (Milano). 1993 Feb;5(1):27-37. doi: 10.1007/BF03324123.
4
Surgical bleeding: unexpected effect of a calcium antagonist.
BMJ. 1995 Mar 25;310(6982):776-7. doi: 10.1136/bmj.310.6982.776.
5
Apparatchiks of science share their anxiety.科学机构的官员们分享着他们的焦虑。
Lancet. 1995 Sep 9;346(8976):689. doi: 10.1016/s0140-6736(95)92288-1.
6
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.硝苯地平。冠心病患者死亡率呈剂量相关增加。
Circulation. 1995 Sep 1;92(5):1326-31. doi: 10.1161/01.cir.92.5.1326.
7
The risk of myocardial infarction associated with antihypertensive drug therapies.与抗高血压药物治疗相关的心肌梗死风险。
JAMA. 1995;274(8):620-5.
8
Long-term survival and use of antihypertensive medications in older persons.老年人长期使用抗高血压药物及其生存情况
J Am Geriatr Soc. 1995 Nov;43(11):1191-7. doi: 10.1111/j.1532-5415.1995.tb07393.x.
9
Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies.硝苯地平在治疗高血压急症时相关的心肌缺血或梗死。
Ann Intern Med. 1987 Aug;107(2):185-6. doi: 10.7326/0003-4819-107-2-185.
10
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
Am J Cardiol. 1991 Jun 1;67(15):1295-7. doi: 10.1016/0002-9149(91)90944-g.